Tag: XO RX 2.2F

FDA Clears Angioplasty Platform to Crack, Break, and Dilate Stenosis in Calcified Cardiovascular Disease and Hemodialysis Fistula

Peripheral/Endo Regulatory by 0 comments

Transformative XO Angioplasty Platform Expands with Low-Profile 2.2F and 3.8F Rapid-Exchange (RX) with the Ability to Treat Up to 20cm Lesions with (1) Inflation SALT LAKE CITY, Oct. 27, 2022 /PRNewswire/ — Transit Scientific, a pioneer in developing medical devices to treat […]

Continue Reading →